The use of oxycodone/naloxone in patients with cancer-associated pain and opioid-induced bowel dysfunction: case reports

Rafał J. Kurzawa; Grzegorz Słomian; Artur Kłusek

eISSN: 2081-2833
ISSN: 2081-0016

Medycyna Paliatywna/Palliative Medicine

Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

2/2015
vol. 7

Send email

Copy url:

abstract:

Case report

The use of oxycodone/naloxone in patients with cancer-associated pain and opioid-induced bowel dysfunction: case reports

Rafał J. Kurzawa

,

Grzegorz Słomian

,

Artur Kłusek

Medycyna Paliatywna 2015; 7(2): 145–148

Online publish date: 2015/08/13

View full text Get citation

Moderate to severe chronic pain is one of the main symptoms of cancer. Most of the patients require strong analgesics administration from the third degree of the analgesic ladder as recommended by the World Health Organization (WHO). Bowel dysfunctions, such as constipation are typical side effects during treatment with opioids. In this article one form of causal treatment was presented. It consisted in replacing previously used opioids to oxycodone/naloxone as prolonged release tablets. In addition the problem of co-existing risk factors of constipation and the treatment of pain in patients with cognitive impairment were submitted.

keywords:

The use of oxycodone/naloxone in patients with cancer-associated pain and opioid-induced bowel dysfunction: case reports

Rafał J. Kurzawa , Grzegorz Słomian , Artur Kłusek

pain, opioid-induced constipation, oxycodone/naloxone

Rafał J. Kurzawa

,

Grzegorz Słomian

,

Artur Kłusek